IL186779A - Preparations to encourage blood arrest and other physiological activities - Google Patents

Preparations to encourage blood arrest and other physiological activities

Info

Publication number
IL186779A
IL186779A IL186779A IL18677907A IL186779A IL 186779 A IL186779 A IL 186779A IL 186779 A IL186779 A IL 186779A IL 18677907 A IL18677907 A IL 18677907A IL 186779 A IL186779 A IL 186779A
Authority
IL
Israel
Prior art keywords
compositions
physiological activities
promoting hemostasis
hemostasis
promoting
Prior art date
Application number
IL186779A
Other languages
English (en)
Hebrew (he)
Other versions
IL186779A0 (en
Original Assignee
Massachusetts Inst Technology
Versitech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36939225&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL186779(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Massachusetts Inst Technology, Versitech Ltd filed Critical Massachusetts Inst Technology
Publication of IL186779A0 publication Critical patent/IL186779A0/en
Publication of IL186779A publication Critical patent/IL186779A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G23/00—Compounds of titanium
    • C01G23/04—Oxides; Hydroxides
    • C01G23/047—Titanium dioxide
    • C01G23/07—Producing by vapour phase processes, e.g. halide oxidation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J21/00—Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
    • B01J21/06—Silicon, titanium, zirconium or hafnium; Oxides or hydroxides thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J37/00—Processes, in general, for preparing catalysts; Processes, in general, for activation of catalysts
    • B01J37/08—Heat treatment
    • B01J37/10—Heat treatment in the presence of water, e.g. steam
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nanotechnology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Environmental & Geological Engineering (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geology (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL186779A 2005-04-25 2007-10-18 Preparations to encourage blood arrest and other physiological activities IL186779A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67461205P 2005-04-25 2005-04-25
US75882706P 2006-01-13 2006-01-13
PCT/US2006/015850 WO2006116524A1 (en) 2005-04-25 2006-04-25 Compositions and methods for promoting hemostasis and other physiological activities

Publications (2)

Publication Number Publication Date
IL186779A0 IL186779A0 (en) 2008-03-20
IL186779A true IL186779A (en) 2016-05-31

Family

ID=36939225

Family Applications (3)

Application Number Title Priority Date Filing Date
IL186779A IL186779A (en) 2005-04-25 2007-10-18 Preparations to encourage blood arrest and other physiological activities
IL245530A IL245530A (en) 2005-04-25 2016-05-08 Preparations and methods to encourage blood clotting and physiological activities
IL250767A IL250767B (en) 2005-04-25 2017-02-26 Preparations and methods to encourage blood stasis and physiological activities

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL245530A IL245530A (en) 2005-04-25 2016-05-08 Preparations and methods to encourage blood clotting and physiological activities
IL250767A IL250767B (en) 2005-04-25 2017-02-26 Preparations and methods to encourage blood stasis and physiological activities

Country Status (11)

Country Link
US (3) US9327010B2 (enExample)
EP (2) EP2283851B1 (enExample)
JP (3) JP5204646B2 (enExample)
KR (2) KR20100102750A (enExample)
CN (1) CN101267831B (enExample)
AU (1) AU2006241123B2 (enExample)
CA (1) CA2609656C (enExample)
DK (1) DK1879606T3 (enExample)
ES (1) ES2427565T3 (enExample)
IL (3) IL186779A (enExample)
WO (1) WO2006116524A1 (enExample)

Families Citing this family (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4023240A1 (en) * 2004-07-06 2022-07-06 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
US9327010B2 (en) 2005-04-25 2016-05-03 Massachusetts Institute Of Technology Compositions and methods for promoting hemostasis and other physiological activities
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
WO2007059171A2 (en) * 2005-11-14 2007-05-24 University Of Utah Research Foundation Electrostatically controlled hydrogels
CN101472620A (zh) * 2006-04-25 2009-07-01 麻省理工学院 用于影响污染物、机体流体或其它实体移动和/或影响其它生理状况的组合物和方法
AU2014203694B2 (en) * 2006-04-25 2016-08-11 Massachusetts Institute Of Technology Compositions and methods for affecting movement of contaminants, bodily fluids or other entities and/or affecting other physiological conditions
US8022178B2 (en) 2006-09-26 2011-09-20 Massachusetts Institute Of Technology Modified self-assembling peptides
US7696309B2 (en) 2006-10-23 2010-04-13 The Brigham And Women's Hospital, Inc. Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
DK2089047T3 (da) * 2006-12-11 2013-02-18 3D Matrix Inc Sammensætninger og fremgangsmåder til beskyttelse og regenerering af hjerte-væv
DK2146733T3 (da) * 2007-03-14 2021-01-11 Arch Biosurgery Inc Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
EP2157937B1 (en) 2007-06-04 2017-03-22 Sequent Medical, Inc. Devices for treatment of vascular defects
US7906478B2 (en) 2007-07-20 2011-03-15 The Procter & Gamble Company Personal-care articles having self-assembling peptides
GB0722820D0 (en) 2007-11-21 2008-01-02 Smith & Nephew Vacuum assisted wound dressing
WO2009067711A2 (en) 2007-11-21 2009-05-28 T.J. Smith & Nephew, Limited Suction device and dressing
EP3354243A1 (en) 2007-11-21 2018-08-01 Smith & Nephew PLC Wound dressing
EP2229960B1 (en) * 2007-12-05 2015-04-08 3-D Matrix, Ltd. Wound healing/skin reconstruction material
GB0723875D0 (en) 2007-12-06 2008-01-16 Smith & Nephew Wound management
US20130096518A1 (en) 2007-12-06 2013-04-18 Smith & Nephew Plc Wound filling apparatuses and methods
US11253399B2 (en) 2007-12-06 2022-02-22 Smith & Nephew Plc Wound filling apparatuses and methods
US20090169521A1 (en) * 2007-12-31 2009-07-02 Technion Research & Development Foundation Ltd. Vascularized cardiac tissue and methods of producing and using same
GB0803564D0 (en) 2008-02-27 2008-04-02 Smith & Nephew Fluid collection
US8852558B2 (en) * 2008-03-11 2014-10-07 Materials Modification, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst
US8828358B2 (en) * 2008-03-11 2014-09-09 Materials Modifications, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
CA2716010C (en) * 2008-04-03 2019-10-01 Zymogenetics, Inc. Hemostatic microspheres
BRPI0911923B8 (pt) 2008-05-02 2021-06-22 Sequent Medical Inc dispositivo para tratamento de um aneurisma cerebral
CN101302249B (zh) * 2008-06-24 2011-08-17 四川大学 一种自组装短肽及其在制备抗肿瘤药物中的应用
EP2345433B1 (en) * 2008-10-06 2017-03-01 3-D Matrix, Ltd. Tissue plug
CN101514225B (zh) * 2008-10-13 2011-09-14 西安蓝晶生物科技有限公司 自聚体多肽及其制备方法和应用
GB0902816D0 (en) 2009-02-19 2009-04-08 Smith & Nephew Fluid communication path
KR101736169B1 (ko) * 2009-03-16 2017-05-16 닛산 가가쿠 고교 가부시키 가이샤 저분자 겔화제로 이루어진 스프레이용 기재
WO2010148400A1 (en) * 2009-06-19 2010-12-23 Vanderbilt University Direct visualization catheter
US20110081398A1 (en) * 2009-10-01 2011-04-07 Tyco Healthcare Group Lp Multi-mechanism surgical compositions
US20110152993A1 (en) 2009-11-05 2011-06-23 Sequent Medical Inc. Multiple layer filamentary devices or treatment of vascular defects
US9439941B2 (en) 2009-12-14 2016-09-13 The University Of Hong Kong Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells
US20110143993A1 (en) * 2009-12-15 2011-06-16 The Brigham And Women's Hospital, Inc. Endothelial basement membrane targeting peptide ligands
US9308277B2 (en) 2010-02-25 2016-04-12 Mesoblast International Sàrl Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
US9067084B2 (en) 2010-03-31 2015-06-30 Agency For Science, Technology And Research Amphiphilic linear peptide/peptoid and hydrogel comprising the same
US8999916B2 (en) 2010-03-31 2015-04-07 Agency For Science, Technology And Research Crosslinked peptide hydrogels
US9687591B2 (en) 2010-03-31 2017-06-27 Agency For Science, Technology And Research Building stratified biomimetic tissues and organs using crosslinked ultrashort peptide hydrogel membranes
US9061095B2 (en) 2010-04-27 2015-06-23 Smith & Nephew Plc Wound dressing and method of use
GB201011173D0 (en) 2010-07-02 2010-08-18 Smith & Nephew Provision of wound filler
US8741833B2 (en) 2010-07-16 2014-06-03 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
BR112013012785A2 (pt) 2010-11-25 2020-10-20 Bluestar Silicones France Sas composição i - ii e produtos e usos das mesmas
GB201020005D0 (en) 2010-11-25 2011-01-12 Smith & Nephew Composition 1-1
US8546338B2 (en) 2010-12-08 2013-10-01 Johnson & Johnson Consumer Companies, Inc. Self-assembling hydrogels based on dicephalic peptide amphiphiles
JP6084352B2 (ja) * 2010-12-24 2017-02-22 国立大学法人 岡山大学 高強度ペプチドゲル
US10662234B2 (en) 2011-06-07 2020-05-26 Mesoblast International Sàrl Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1
EP2741788A4 (en) 2011-08-14 2015-03-25 Materials Modification Inc METHOD AND COMPOSITION FOR IN-SITU FORMATION OF AN ARTIFICIAL BARRIER FOR FIGHTING BLOOD LOSS
ES2653667T3 (es) * 2011-09-02 2018-02-08 3-D Matrix, Ltd. Péptidos anfifílicos para la oclusión del escape de aire torácico
US10905708B2 (en) 2011-09-07 2021-02-02 3-D Matrix, Ltd. MicroRNA-based methods and assays for osteocarcinoma
US11260072B2 (en) 2011-09-07 2022-03-01 3-D Matrix, Ltd. MicroRNA-based methods and assays for osteocarcinoma
GB2496654A (en) * 2011-11-18 2013-05-22 Reckitt & Colman Overseas Self-assembling peptides
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
JP6389170B2 (ja) * 2012-07-06 2018-09-12 スリーディー マトリックス， エルティーディー３−Ｄ Ｍａｔｒｉｘ， Ｌｔｄ． ペプチド溶液のためのフィル−フィニッシュ過程
JP6183831B2 (ja) 2012-10-23 2017-08-23 義之 小山 ハイドロゲル形成材
US9241891B2 (en) 2012-10-30 2016-01-26 The Procter & Gamble Company Personal care compositions comprising self-assembling peptides
EP2939602B1 (en) 2012-12-25 2021-04-14 Fuso Pharmaceutical Industries, Ltd. Hemostatic agent applicator
CN105102469A (zh) * 2013-01-28 2015-11-25 新加坡科技研究局 交联的肽水凝胶
KR101432276B1 (ko) * 2013-02-06 2014-08-21 주식회사 이노테라피 총경동맥 또는 상시상 정맥동에 출혈이 유발된 지혈제 성능평가 동물모델 및 그 용도
KR102045030B1 (ko) * 2013-02-08 2019-11-15 재단법인 아산사회복지재단 지혈요소가 구비된 의료기구
KR20190102101A (ko) * 2013-03-06 2019-09-02 가부시끼가이샤 쓰리디 매트릭스 정제된 양친매성 펩타이드 조성물을 이용하는 수술 방법
EP2968135A4 (en) 2013-03-14 2016-10-26 Massachusetts Inst Technology INJECTABLE, MULTILAYER, SELF-COMPOSITE PEPTIDE RUBBER HYDROGELS FOR LONG-TERM AND DELAYED RELEASE OF HUMAN ANTIBODIES
JP2016513523A (ja) * 2013-03-14 2016-05-16 株式会社スリー・ディー・マトリックス 胆汁漏の処置
US20160120706A1 (en) 2013-03-15 2016-05-05 Smith & Nephew Plc Wound dressing sealant and use thereof
EP2968647B1 (en) 2013-03-15 2022-06-29 Smith & Nephew plc Wound dressing sealant and use thereof
US11931227B2 (en) * 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
CN105050630A (zh) * 2013-03-15 2015-11-11 库克医药技术有限责任公司 粘合剂医学产品和治疗胃肠病损的方法
JP6857857B2 (ja) * 2013-04-30 2021-04-14 国立大学法人九州工業大学 ペプチドおよびその自己集合方法、その集合体、これらを用いた細胞培養基材、並びに、細胞シートの製造方法
US10765774B2 (en) * 2013-07-09 2020-09-08 Ethicon, Inc. Hemostatic pad assembly kit and method
US9955976B2 (en) 2013-08-16 2018-05-01 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9078658B2 (en) 2013-08-16 2015-07-14 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
CN105658252A (zh) * 2013-08-22 2016-06-08 阿奇生物外科有限公司 用于控制流体移动的可植入网状物
CN103656618B (zh) * 2013-10-25 2016-06-08 广东药学院 治疗皮肤创伤的多肽纳米纤维凝胶制剂、制备方法及应用
CN103665110B (zh) * 2013-12-06 2015-10-28 华南理工大学 半程电荷互补型手性自组装短肽纳米生物医药材料及应用
JP2015142720A (ja) * 2013-12-27 2015-08-06 株式会社メニコン 止血材
JP6490897B2 (ja) * 2013-12-27 2019-03-27 株式会社メニコンネクト 自己組織化ペプチドゲル
CA2939696C (en) 2014-03-10 2023-01-10 3-D Matrix, Ltd. Self-assembling peptide compositions
ES2712608T3 (es) 2014-03-10 2019-05-14 3 D Matrix Ltd Péptidos autoensamblantes para el tratamiento de las bullas pulmonares
JP6684719B2 (ja) 2014-03-10 2020-04-22 株式会社スリー・ディー・マトリックス ペプチド組成物の滅菌および濾過
EP3124058A4 (en) * 2014-03-28 2017-11-29 Otsuka Chemical Co., Ltd. Hemostatic pharmaceutical composition
US9629635B2 (en) 2014-04-14 2017-04-25 Sequent Medical, Inc. Devices for therapeutic vascular procedures
AU2015288635B2 (en) * 2014-07-11 2018-07-26 Menicon Co., Ltd. Visibility-ensuring material, and device for discharging visibility-ensuring material
DE102015000363A1 (de) 2015-01-20 2016-07-21 Emc Microcollections Gmbh Neue modular funktionalisierbare Peptid-Hydrogele
US11298397B2 (en) 2015-12-18 2022-04-12 3-D Matrix, Ltd. Hemostatic composition and hemostatic method using hemostatic composition
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
US20190091376A1 (en) * 2016-03-18 2019-03-28 3-D Matrix, Ltd. Preventing Biological Tissue Adhesion
MX2018011120A (es) * 2016-03-18 2019-03-28 3 D Matrix Ltd Oclusion de fistula pancreatica.
US20210023257A1 (en) * 2016-03-18 2021-01-28 3-D Matrix, Ltd. Cerebrospinal fluid leakage occlusion
US20190275196A1 (en) * 2016-06-01 2019-09-12 Eun Seok Gil Hemostatic Powders with Self-Assembling Peptide Hydrogels
EP3463495A1 (en) * 2016-06-01 2019-04-10 3-D Matrix Ltd. Hemostatic dressings with self-assembling peptide hydrogels
JP6912953B2 (ja) * 2016-06-27 2021-08-04 三洋化成工業株式会社 体液漏出防止剤
JP7012950B2 (ja) 2016-11-17 2022-01-31 地方独立行政法人東京都立産業技術研究センター 生体組織孔閉鎖用、潰瘍保護用及び血管塞栓療術用ゾル
US11174288B2 (en) * 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
CN106701724B (zh) * 2016-12-27 2019-10-08 江南大学 一种碱性果胶酶活性包涵体的制备及其应用
CN107529533B (zh) * 2017-09-07 2020-10-30 中国药科大学 一类可自组装成水凝胶的pH敏感多肽及其作为装载药物材料的应用
KR101989054B1 (ko) * 2017-11-28 2019-06-13 (주)다림티센 지혈용 조성물 및 이를 포함하는 용기
CN107802883B (zh) * 2017-12-09 2020-08-14 青岛市妇女儿童医院 一种伤口清洗液
EP3723726A1 (en) 2017-12-15 2020-10-21 3-D Matrix, Ltd. Surfactant peptide nanostructures and uses in drug delivery
EP3768296B1 (en) * 2018-03-23 2023-09-06 Arch Biosurgery, Inc. Sap and peptidomimetics for treatment of eye disease
CA3094984A1 (en) 2018-03-23 2019-09-26 Arch Biosurgery, Inc. Sap and peptidomimetic compositions for reducing symptoms of inflammation
CN108517006B (zh) * 2018-05-10 2021-05-28 暨南大学 一种常温常压条件下改善碳纳米管在水中分散性的多肽材料及其应用
JP7142286B2 (ja) * 2018-07-13 2022-09-27 慶應義塾 セレン含有アミノ酸を含む糖鎖－ポリペプチド複合体、および、その医薬用途
WO2020071527A1 (ja) * 2018-10-05 2020-04-09 学校法人 久留米大学 腸管における潰瘍または瘻孔の治療または予防のための医薬組成物
MX2021003930A (es) * 2018-10-05 2021-06-04 Basf Se Compuestos estabilizadores de hidrolasas en liquidos.
CN109136165A (zh) * 2018-10-16 2019-01-04 罗忠礼 一种自组装短肽在皮肤组织创伤中快速修复的应用
CN109646711A (zh) * 2019-01-29 2019-04-19 青岛中腾生物技术有限公司 一种医用止血封闭防黏连材料
EP3908209A4 (en) 2019-03-15 2022-10-19 Sequent Medical, Inc. FIBROUS DEVICES FOR TREATMENT OF VASCULAR DEFECTS
US11317921B2 (en) 2019-03-15 2022-05-03 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
EP3908208A4 (en) 2019-03-15 2022-10-19 Sequent Medical, Inc. FILAMENTAL DEVICES WITH A FLEXIBLE CONNECTION FOR TREATMENT OF VASCULAR DEFECTS
CN110256572B (zh) * 2019-05-07 2022-11-01 西北大学 一种rhc-(rada)4融合蛋白
EP3952973B1 (en) 2019-06-13 2023-06-07 Hollister Incorporated Reusable urinary catheter products
AU2020304005B2 (en) 2019-06-25 2025-12-04 Hollister Incorporated Reusable urinary catheter products
CN110396124B (zh) * 2019-08-21 2021-04-13 上海交通大学 自组装多肽及其作为止血剂的用途
EP4090350A1 (en) 2020-01-13 2022-11-23 Arch Biosurgery, Inc. Self-assembling peptide gel formulation and methods of use
WO2021183793A2 (en) 2020-03-11 2021-09-16 Microvention, Inc. Devices for treatment of vascular defects
US20210282789A1 (en) 2020-03-11 2021-09-16 Microvention, Inc. Multiple layer devices for treatment of vascular defects
US12070220B2 (en) 2020-03-11 2024-08-27 Microvention, Inc. Devices having multiple permeable shells for treatment of vascular defects
CN111848736B (zh) * 2020-08-05 2021-12-31 赛克赛斯生物科技股份有限公司 自组装多肽、制备方法、自组装多肽制剂及应用
CN112386737B (zh) * 2020-11-23 2022-07-26 上海交通大学 一种限制伤口部位的体液溢出的组合物
CN113046884B (zh) * 2021-03-25 2022-06-10 台州市中心医院（台州学院附属医院） 一种抗菌可降解医用缝合线
US12446891B2 (en) 2021-08-30 2025-10-21 Microvention, Inc. Devices for treatment of vascular defects
CN114230640A (zh) * 2021-12-21 2022-03-25 西安交通大学 一种具有自组装能力的氨基酸缩合物
US20240139380A1 (en) * 2022-05-04 2024-05-02 Massachusetts Institute Of Technology Formulations and medical devices for minimally-invasive deep tissue applications
CN115252810B (zh) * 2022-05-26 2025-06-27 安徽中医药大学 一种可变形态的喜树碱多肽纳米制剂及其制备方法和应用

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1006606A (en) 1961-05-12 1965-10-06 Fmc Corp Haemostatic wound dressing
US4098728A (en) * 1976-01-02 1978-07-04 Solomon Rosenblatt Medical surgical sponge and method of making same
US4211227A (en) * 1978-07-03 1980-07-08 The Kendall Company Surgical sponge material
US4272398A (en) * 1978-08-17 1981-06-09 The United States Of America As Represented By The Secretary Of Agriculture Microencapsulation process
US4636208A (en) 1984-10-05 1987-01-13 Ewald Rath Surgical sponge
US4829000A (en) 1985-08-30 1989-05-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Reconstituted basement membrane complex with biological activity
US4861627A (en) * 1987-05-01 1989-08-29 Massachusetts Institute Of Technology Preparation of multiwall polymeric microcapsules
US5019646A (en) 1987-08-25 1991-05-28 Regents Of The University Of Minnesota Polypeptides with fibronectin activity
US5843156A (en) 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US5126141A (en) * 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
JP2528602B2 (ja) 1989-12-04 1996-08-28 ケンゼー・ナッシュ・コーポレーション 開口部を封止するためのプラグ装置
US5180375A (en) 1991-05-02 1993-01-19 Feibus Miriam H Woven surgical drain and woven surgical sponge
US5222974A (en) 1991-11-08 1993-06-29 Kensey Nash Corporation Hemostatic puncture closure system and method of use
JPH05204646A (ja) 1992-01-28 1993-08-13 Mitsubishi Electric Corp 知識処理システム
US5955343A (en) * 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5670483A (en) * 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
FR2715309B1 (fr) 1994-01-24 1996-08-02 Imedex Composition adhésive, à usage chirurgical, à base de collagène modifié par coupure oxydative et non réticulé.
US6413539B1 (en) 1996-10-31 2002-07-02 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
AU5638096A (en) 1995-06-07 1996-12-30 Clarion Pharmaceuticals, Inc. Non-biological patch for hemostasis
US5645565A (en) * 1995-06-13 1997-07-08 Ethicon Endo-Surgery, Inc. Surgical plug
HUP9903586A3 (en) 1996-04-04 2003-02-28 Baxter Ag Hemostatic sponge based on collagen
US6489446B1 (en) * 1996-08-07 2002-12-03 Hsc Research And Development Limited Partnership Self-aligning peptides modeled on human elastin and other fibrous proteins
US6177609B1 (en) 1997-03-10 2001-01-23 Meadox Medicals, Inc. Self-aggregating protein compositions and use as sealants
US5906997A (en) 1997-06-17 1999-05-25 Fzio Med, Inc. Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US6368877B1 (en) * 1997-06-25 2002-04-09 Massachusetts Institute Of Technology Self-assembling peptide surfaces for cell patterning and interactions
US6235340B1 (en) 1998-04-10 2001-05-22 Massachusetts Institute Of Technology Biopolymer-resistant coatings
JP4159682B2 (ja) 1998-12-22 2008-10-01 株式会社クラレ 止血材
WO2000041732A1 (en) * 1999-01-19 2000-07-20 The Children's Hospital Of Philadelphia Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
WO2000063079A1 (en) * 1999-04-15 2000-10-26 Ultracell Medical Technologies Of Connecticut, Inc. Method for producing surgical sponge device and product thereof
JP4596341B2 (ja) 1999-11-11 2010-12-08 オリンパステルモバイオマテリアル株式会社 液体状創傷被覆材
US6844324B1 (en) * 1999-11-12 2005-01-18 Massachusetts Institute Of Technology Modular peptide mediated intracellular delivery system and uses therefore
JP2003520050A (ja) * 2000-01-24 2003-07-02 フィロス インク． タンパク質分析のための高感度多重化診断アッセイ法
EP1292316B1 (en) 2000-04-28 2009-03-18 Fziomed Inc. Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use
US6953659B2 (en) * 2000-07-14 2005-10-11 Massachusetts Institute Of Technology Direct, externally imposed control of nucleic acids
US6953656B2 (en) * 2000-07-14 2005-10-11 Massachusetts Institute Of Technology Direct, externally imposed control of polypeptides
US6846319B2 (en) 2000-12-14 2005-01-25 Core Medical, Inc. Devices for sealing openings through tissue and apparatus and methods for delivering them
BRPI0206708B8 (pt) 2001-01-25 2021-06-22 Nycomed Pharma As composição sólida, composição para hemostasia, vedação de tecido e colagem de tecido, e, usos de um veículo de colágeno
US7449180B2 (en) * 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
ATE419333T1 (de) 2001-02-06 2009-01-15 Massachusetts Inst Technology Peptidgerüstverkapselung von gewebszellen und verwendungen davon
JP3838882B2 (ja) 2001-02-28 2006-10-25 株式会社Ｐｈｇ 温度応答性材料およびそれを含む組成物
EP1402001A4 (en) 2001-05-04 2006-05-24 Scripps Research Inst ANTIMICROBIAL PEPTIDES AND COMPOSITIONS
US7303759B2 (en) 2001-06-22 2007-12-04 The United States Of America As Represented By The Secretary Of The Army Compositions and methods for reducing blood and fluid loss from open wounds
WO2003006043A1 (en) * 2001-07-10 2003-01-23 Massachusetts Institute Of Technology Surfactant peptide nanostructures, and uses thereof
WO2003052117A2 (en) * 2001-09-19 2003-06-26 Massachusetts Institute Of Technology Methods and products related to non-viral transfection
JP2003252936A (ja) 2002-02-28 2003-09-10 Sentomedo:Kk 温度応答性材料及びそれを含む組成物
WO2003084980A2 (en) 2002-04-02 2003-10-16 Northwestern University Peptide amphiphile solutions and self assembled peptide nanofiber networks
WO2003096972A2 (en) 2002-05-13 2003-11-27 Massachusetts Institute Of Technology Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
CA2387257C (en) * 2002-05-23 2009-07-28 Suncor Energy Inc. Static deaeration conditioner for processing of bitumen froth
GB0216286D0 (en) 2002-07-15 2002-08-21 Univ Leeds Network
JP2005534697A (ja) * 2002-08-06 2005-11-17 エピックス ファーマシューティカルズ， インコーポレイテッド ペプチド凝集体
WO2004110964A2 (en) 2003-06-16 2004-12-23 Nuevolution A/S Encoded molecules by translation (emt)
DK1636250T3 (en) * 2003-06-25 2016-02-22 Massachusetts Inst Technology SELF-ORGANIZING PEPTIDES, CONTAINING MODIFICATIONS, AND APPLICATIONS THEREOF
US7713923B2 (en) * 2003-06-25 2010-05-11 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
CA2530421C (en) * 2003-06-27 2015-04-21 Ethicon, Incorporated Repair and regeneration of ocular tissue using postpartum-derived cells
JP2005074079A (ja) 2003-09-02 2005-03-24 Masao Tanihara 止血材
US7846891B2 (en) * 2003-10-17 2010-12-07 Massachusetts Institute Of Technology Self-assembling peptides for regeneration and repair of neural tissue
US20050266086A1 (en) * 2004-06-01 2005-12-01 Sawhney Amarpreet S Intrauterine applications of materials formed in situ
EP4023240A1 (en) 2004-07-06 2022-07-06 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
US7884185B2 (en) 2004-07-28 2011-02-08 University Of Delaware Hydrogels and uses thereof
US8039258B2 (en) 2004-09-28 2011-10-18 Ethicon, Inc. Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
US7399831B2 (en) * 2004-10-25 2008-07-15 The Brigham And Women's Hospital, Inc. Targeted delivery of biological factors using self-assembling peptide nanofibers
US7429567B2 (en) * 2005-01-04 2008-09-30 The Brigham And Women's Hospital, Inc. Sustained delivery of PDGF using self-assembling peptide nanofibers
US9327010B2 (en) 2005-04-25 2016-05-03 Massachusetts Institute Of Technology Compositions and methods for promoting hemostasis and other physiological activities
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
CN101472620A (zh) 2006-04-25 2009-07-01 麻省理工学院 用于影响污染物、机体流体或其它实体移动和/或影响其它生理状况的组合物和方法
US8021570B2 (en) 2006-06-13 2011-09-20 Wisconsin Alumni Research Foundation β-peptide lyotropic liquid crystals and methods of manufacture and use thereof
US8022178B2 (en) * 2006-09-26 2011-09-20 Massachusetts Institute Of Technology Modified self-assembling peptides
DK2146733T3 (da) * 2007-03-14 2021-01-11 Arch Biosurgery Inc Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
US20120085262A1 (en) 2010-08-26 2012-04-12 Freudenberg Forschungsdienste Kg Production of Highly Concentrated Solutions of Self-Assembling Proteins
CA2865279C (en) 2012-02-22 2023-04-25 Northwestern University Nanostructures for treating cancers and other conditions

Also Published As

Publication number Publication date
DK1879606T3 (da) 2013-09-23
CA2609656C (en) 2016-02-02
AU2006241123A1 (en) 2006-11-02
ES2427565T3 (es) 2013-10-31
CN101267831B (zh) 2013-04-24
IL250767B (en) 2019-02-28
EP2283851B1 (en) 2023-06-07
EP1879606A1 (en) 2008-01-23
CA2609656A1 (en) 2006-11-02
US20160296660A1 (en) 2016-10-13
EP2283851A2 (en) 2011-02-16
US20070203062A1 (en) 2007-08-30
JP5629241B2 (ja) 2014-11-19
HK1112847A1 (en) 2008-09-19
JP2014221830A (ja) 2014-11-27
US11839694B2 (en) 2023-12-12
IL245530A (en) 2017-03-30
IL245530A0 (en) 2016-06-30
KR20100102750A (ko) 2010-09-24
JP2011168623A (ja) 2011-09-01
AU2006241123B2 (en) 2013-10-03
US9364513B2 (en) 2016-06-14
EP1879606B1 (en) 2013-06-12
IL186779A0 (en) 2008-03-20
EP2283851A3 (en) 2011-06-08
JP2008539257A (ja) 2008-11-13
US9327010B2 (en) 2016-05-03
IL250767A0 (en) 2017-04-30
KR20080007380A (ko) 2008-01-18
CN101267831A (zh) 2008-09-17
JP5204646B2 (ja) 2013-06-05
WO2006116524A1 (en) 2006-11-02
US20090111734A1 (en) 2009-04-30

Similar Documents

Publication Publication Date Title
IL250767B (en) Preparations and methods to encourage blood stasis and physiological activities
IL191137A0 (en) Polycation-polyanion complexes, compositions and methods of use thereof
IL223477A (en) Pharmaceutical preparation containing modified enzyme uricase
PL2041254T3 (pl) Przyjazne skórze kompozycje dezynfekcyjne o szerokim spektrum
PL1951838T3 (pl) Kompozycje zawierające fluoroolefiny i ich zastosowania
GB0715203D0 (en) Skin care compositions
EP1968483A4 (en) BIOABSORBABLE SURGICAL COMPOSITION
IL245513A0 (en) Medical preparations containing ingenol-3-angelate
EP1909780A4 (en) AGAINST TUBERCULOSIS, COMPOSITIONS AND PROCEDURES
ZA200804026B (en) Compositions and methods for modulating hemostasis
PL2335782T3 (pl) Zastosowanie kompozycji zawierającej HFCO-1233zd
PL1809342T3 (pl) Wchłanialny hemostat
IL191072A0 (en) Therapeutic compositions and methods
PT1883665T (pt) Composições polilactídeo e usos das mesmas
EP2064300A4 (en) ADHESIVE FABRIC COMPOSITIONS AND RELATED METHODS
PL3470492T3 (pl) Kompozycje zawierające hfc-1234ze i hfc-227ea
IL190239A0 (en) Pharmaceutical gallium compositions and methods
EP1962867A4 (en) BIOCOMPATIBLE SURGICAL COMPOSITIONS
EP1913385A4 (en) TISSUE CARBOHYDRATE COMPOSITIONS AND ANALYSIS THEREOF
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
PL1863899T3 (pl) Kompozycje do leczenia skóry
EP1879449A4 (en) SKIN CARE COMPOSITIONS AND METHODS
IL185753A0 (en) Methods and compositions for modulating vascular integrity
LT1858481T (lt) Oftalmologinės kompozicijos ir jų panaudojimas
IL186337A0 (en) Stannsoporfin compositions and administration

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed